RegeneRx Biopharmaceuticals, Inc. · OTC:RGRX

RegeneRx Biopharmaceuticals, Inc. financial statements

RegeneRx Biopharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013
Revenue76.8K76.8K76.8K76.8K69.7K56.7K93.3K60.6K029.0K
Cost of revenue65.1K81.0K143.9K237.3K203.2K367.3K938.0K
Gross profit76.8K-11.4K-87.3K-144.0K-142.6K-367.3K-909.0K
Research and development06.64K4.92K65.1K81.0K143.9K237.3K203.0K367.0K189.0K
Selling, general and administrative1.48M1.40M1.37M1.27M1.31M1.36M1.53M1.57M1.55M
Operating income-1.40M-1.33M-1.29M-1.26M-1.32M-1.44M-1.67M-1.71M-1.56M
Depreciation and amortization1.42K2.75K3.05K3.33K3.40K4.82K
EBITDA-1.26M-1.32M-1.44M-1.67M-1.71M-1.55M
Interest expense325.6K324.9K232.6K153.4K87.3K00000
Income before tax-1.73M-1.60M-1.52M-1.40M-1.99M385.1K229.1K-5.27M-2.75M
Income tax098.6K000
Net income-1.73M-1.60M-1.52M-1.40M-1.99M286.5K229.1K-5.27M-2.75M
Earnings per share, basic-1.20-0.01-0.01-0.01-0.020.00

Balance sheet

LineFY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013
Cash and equivalents290.9K1.23M427.9K639.9K237.3K181.7K769.5K317.6K844.0K6.00K
Current assets306.9K1.25M477.8K681.6K273.9K217.2K849.4K341.9K930.6K
Property, plant and equipment27.7K68.2K24.5K1.42K4.17K7.22K10.5K13.0K4.00K
Total assets382.2K1.28M551.8K711.8K281.0K227.1K862.4K358.2K949.0K43.0K
Accounts payable63.8K63.6K39.3K43.7K92.4K66.5K75.7K141.1K233.0K577.0K
Current liabilities553.7K429.9K399.6K242.5K315.0K2.15M659.8K359.0K410.0K616.0K
Long-term debt1.37M1.14M923.8K708.1K43.8K512.0K688.9K566.0K432.0K
Total liabilities3.83M3.51M3.38M3.05M2.49M4.34M6.93M7.10M2.66M1.66M
Shareholders' equity-3.45M-2.23M-2.82M-2.34M-2.21M-4.12M-6.07M-6.74M-1.71M-1.62M
Shares outstanding1.44M143.5M133.4M131.5M128.4M109.8M

Cash flow

LineFY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013
Cash from operations-940.7K-990.3K-1.01M-1.14M-888.3K-663.1K-1.07M-525.3K-1.70M
Capital spending0000000-1.08K-13.0K0
Free cash flow-940.7K-990.3K-1.01M-1.14M-888.3K-663.1K-1.07M-526.4K-1.72M
Cash from investing-1.08K-13.3K
Cash from financing01.79M794.9K1.54M943.8K75.3K1.52M1.52M2.56M646.0K
Share buybacks75.3K1.52M1.52M2.50M
Change in cash-940.7K803.7K-212.0K402.7K55.6K-587.8K451.9K-526.4K837.7K